Study title: Conclusions regarding the influence of Piracetam upon the cognitive learning symptoms of children with learning disabilities.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Nervous System Diseases | |||||
Brands: Please see report, Please see report | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: PIRACETAM | |||||
ATC code: N06BX03 | |||||
Document link: DE75G011 - Piracetam.pdf | |||||
Document date: 2011-11-28 | |||||
Study number: DE75G011 | |||||
EudraCT number: | |||||
Scope of study: | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |